Orsobio, Inc
Clinical trials sponsored by Orsobio, Inc, explained in plain language.
-
New obesity drug TLC-6740 enters early human trials
Disease control Recruiting nowThis early-stage study tests a new drug called TLC-6740 in healthy volunteers and people with obesity, with or without type 2 diabetes. The goal is to check the drug's safety, how the body processes it, and its potential to help with weight and blood sugar control. About 564 part…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Healthy volunteers needed to test safety of experimental drug TLC-1180
Knowledge-focused Recruiting nowThis early-stage study tests the safety of a new drug, TLC-1180, in healthy adults aged 18 to 55. Researchers will give single or multiple doses to see how the body handles the drug and if it causes side effects. About 288 participants will take part. This study does not aim to t…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Knowledge-focused
Last updated May 26, 2026 02:21 UTC